{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T21:16:22Z","timestamp":1783631782593,"version":"3.55.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015969","name":"Fay Fuller Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001786","name":"University of Adelaide","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001786","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.bbi.2024.09.003","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T10:31:57Z","timestamp":1725618717000},"page":"43-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo"],"prefix":"10.1016","volume":"123","author":[{"given":"Emma","family":"Sampson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie T.","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah","family":"Cearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schwarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"Hohoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Oliver Schubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9lia","family":"Fourrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard T.","family":"Baune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2024.09.003_b0005","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jad.2012.03.033","article-title":"Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study","volume":"141","author":"Abbasi","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbi.2024.09.003_b0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/da.20589","article-title":"Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial","volume":"26","author":"Akhondzadeh","year":"2009","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbi.2024.09.003_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v067.i01","article-title":"Fitting linear mixed-effects models using lme4","volume":"67","author":"Bates","year":"2015","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2024.09.003_b0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.euroneuro.2021.07.092","article-title":"No evidence for clinical efficacy of adjunctive celecoxib with vortioxetine in the treatment of depression: A 6-week double-blind placebo controlled randomized trial","volume":"53","author":"Baune","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbi.2024.09.003_b0025","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1001\/jamapsychiatry.2013.1111","article-title":"Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study","volume":"70","author":"Benros","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2024.09.003_b0030","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","article-title":"TNF-mediated inflammatory disease","volume":"214","author":"Bradley","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.bbi.2024.09.003_b0035","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/sj.npp.1300025","article-title":"Acute changes in cerebrospinal Fluid 5-HIAA following oral paroxetine challenge in healthy humans","volume":"28","author":"Carpenter","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbi.2024.09.003_b0040","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/0049124108314720","article-title":"An empirical evaluation of the use of fixed cutoff points in RMSEA test statistic in structural equation models","volume":"36","author":"Chen","year":"2008","journal-title":"Sociol Methods Res"},{"key":"10.1016\/j.bbi.2024.09.003_b0045","doi-asserted-by":"crossref","first-page":"e1026","DOI":"10.1038\/tp.2016.274","article-title":"Recurrence of depressive disorders after interferon-induced depression","volume":"7","author":"Chiu","year":"2017","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2014.03.019","article-title":"The plasma levels of various cytokines are increased during ongoing depression and are reduced to normal levels after recovery","volume":"45","author":"Dahl","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2024.09.003_b0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbi.2006.09.006","article-title":"Twenty years of research on cytokine-induced sickness behavior","volume":"21","author":"Dantzer","year":"2007","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2024.09.003_b0060","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A meta-analysis of cytokines in major depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0065","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/s12144-018-0018-1","article-title":"The interpretation of statistical power after the data have been gathered","volume":"39","author":"Dziak","year":"2020","journal-title":"Curr Psychol"},{"key":"10.1016\/j.bbi.2024.09.003_b0070","unstructured":"Flournoy, J.C., 2017. A better cross-lagged panel model, from Hamaker et al. (2015). <https:\/\/johnflournoy.science\/2017\/10\/20\/riclpm-lavaan-demo\/>, accessed 22\/04\/2024."},{"key":"10.1016\/j.bbi.2024.09.003_b0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1186\/s13063-018-2829-7","article-title":"Anti-inflammatory treatment of depression: study protocol for a randomised controlled trial of vortioxetine augmented with celecoxib or placebo","volume":"19","author":"Fourrier","year":"2018","journal-title":"Trials"},{"key":"10.1016\/j.bbi.2024.09.003_b0080","first-page":"466","article-title":"Dose-dependent development of depressive symptoms during adjuvant interferon-{alpha} treatment of patients with malignant melanoma","volume":"51","author":"Friebe","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.bbi.2024.09.003_b0085","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0090","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40273-021-01019-4","article-title":"The economic burden of adults with major depressive disorder in the united states (2010 and 2018)","volume":"39","author":"Greenberg","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bbi.2024.09.003_b0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1037\/a0038889","article-title":"A critique of the cross-lagged panel model","volume":"20","author":"Hamaker","year":"2015","journal-title":"Psychol Methods"},{"issue":"Suppl 6","key":"10.1016\/j.bbi.2024.09.003_b0100","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0105","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/PSY.0b013e3181907c1b","article-title":"Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Psychosom Med"},{"key":"10.1016\/j.bbi.2024.09.003_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10705519909540118","article-title":"Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives","volume":"6","author":"Hu","year":"1999","journal-title":"Struct. Equ. Model. Multidiscip. J."},{"key":"10.1016\/j.bbi.2024.09.003_b0115","article-title":"Inflammation-stratified augmentation of vortioxetine with celecoxib: results from a double-blind, randomized, placebo-controlled trial in major depressive disorder","author":"Kavakbasi","year":"2023","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbi.2024.09.003_b0120","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","article-title":"Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials","volume":"71","author":"K\u00f6hler","year":"2014","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2024.09.003_b0125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/0269881115609072","article-title":"The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants","volume":"30","author":"K\u00f6hler","year":"2016","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.bbi.2024.09.003_b0130","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","article-title":"Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression","volume":"62","author":"K\u00f6hler-Forsberg","year":"2017","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.bbi.2024.09.003_b0135","doi-asserted-by":"crossref","unstructured":"K\u00f6hler-Forsberg, O., C, N.L., Hjorth\u00f8j, C., et al., 2019. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand 139, 404-419. DOI:10.1111\/acps.13016.","DOI":"10.1111\/acps.13016"},{"key":"10.1016\/j.bbi.2024.09.003_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v082.i13","article-title":"lmertest package: Tests in linear mixed effects models","volume":"82","author":"Kuznetsova","year":"2017","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2024.09.003_b0145","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature21029","article-title":"Neurotoxic reactive astrocytes are induced by activated microglia","volume":"541","author":"Liddelow","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2024.09.003_b0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-\u03b1) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbi.2024.09.003_b0155","first-page":"891","article-title":"A Randomized, double-blind, placebo-controlled trial of celecoxib augmentation of sertraline in treatment of drug-naive depressed women: a pilot study","volume":"14","author":"Majd","year":"2015","journal-title":"Iran J Pharm Res"},{"key":"10.1016\/j.bbi.2024.09.003_b0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0165","unstructured":"Mulder, J.D., Hamaker, E.L., 2021. Using lavaan. <https:\/\/jeroendmulder.github.io\/RI-CLPM\/lavaan.html>, accessed 22\/04\/2024."},{"key":"10.1016\/j.bbi.2024.09.003_b0170","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/sj.mp.4001805","article-title":"The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine","volume":"11","author":"M\u00fcller","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbi.2024.09.003_b0175","doi-asserted-by":"crossref","unstructured":"Murray, M.H., Blume, J.D., 2021. FDRestimation: Flexible False Discovery Rate Computation in R. F1000Res 10, 441. DOI:10.12688\/f1000research.52999.2.","DOI":"10.12688\/f1000research.52999.1"},{"key":"10.1016\/j.bbi.2024.09.003_b0180","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","article-title":"Microglia development and function","volume":"32","author":"Nayak","year":"2014","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.bbi.2024.09.003_b0185","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the american heart association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.bbi.2024.09.003_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v048.i02","article-title":"lavaan}: An {R package for structural equation modeling","volume":"48","author":"Rosseel","year":"2012","journal-title":"J. Stat. Softw."},{"key":"10.1016\/j.bbi.2024.09.003_b0195","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41398-023-02438-x","article-title":"Higher immune-related gene expression in major depression is independent of CRP levels: results from the BIODEP study","volume":"13","author":"Sforzini","year":"2023","journal-title":"Transl Psychiatry"},{"issue":"Suppl 20","key":"10.1016\/j.bbi.2024.09.003_b0200","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","volume":"59","author":"Sheehan","year":"1998","journal-title":"J Clin Psychiatry."},{"key":"10.1016\/j.bbi.2024.09.003_b0205","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bbi.2024.09.003_b0210","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s00401-009-0619-8","article-title":"Astrocytes: biology and pathology","volume":"119","author":"Sofroniew","year":"2010","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.bbi.2024.09.003_b0215","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.bbi.2024.09.003_b0220","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2147\/NDT.S198774","article-title":"Management of treatment-resistant depression: challenges and strategies","volume":"16","author":"Voineskos","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.bbi.2024.09.003_b0225","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","article-title":"Elevated C-reactive protein levels, psychological distress, and depression in 73, 131 individuals","volume":"70","author":"Wium-Andersen","year":"2013","journal-title":"JAMA Psychiat."},{"key":"10.1016\/j.bbi.2024.09.003_b0230","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20m13699","article-title":"The prevalence and national burden of treatment-resistant depression and major depressive disorder in the united states","volume":"82","author":"Zhdanava","year":"2021","journal-title":"J Clin Psychiatry"}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912400597X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912400597X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:40:55Z","timestamp":1762314055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915912400597X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"alternative-id":["S088915912400597X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.003","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term characterisation of the relationship between change in depression severity and change in inflammatory markers following inflammation-stratified treatment with vortioxetine augmented with celecoxib or placebo","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2024.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}